- Jonathan I Bisson, clinical senior lecturer in psychiatry
- Cardiff University, University Hospital of Wales, Cardiff CF14 4XW
Vivid descriptions of reactions to traumatic events span many centuries, although their nature has changed over time.1 Post-traumatic stress disorder was first recognised as a diagnosable psychiatric disorder in the third edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III)w1 and ICD-10 (International Classification of Diseases, 10th edition).2 Its very existence continues to attract debate, with several authors arguing that culturally determined, understandable emotions to traumatic events are being pathologised.w2 However, even its most ardent critics are more concerned by overdiagnosis than by whether post-traumatic stress disorder should be used as a label for the severe mental health problems some people experience after traumatic events.3 This article provides an overview of our current understanding of the disorder, who it affects, and the best approaches to its prevention and management.
Methods
I consulted recent systematic searches used to prepare Cochrane reviews and BMJ Clinical Evidence on prevention and treatment of post-traumatic stress disorder, as well as those used to prepare the National Institute for Health and Clinical Excellence (NICE) guidelines for post-traumatic stress disorder. I searched PubMed using the terms “epidemiology”, “neurobiology”, and “neuroimaging” in conjunction with “post-traumatic stress disorder”. I also used a personal archive of references.
What is post-traumatic stress disorder?
Box 1 shows the characteristic features of the disorder. It occurs after a traumatic event that involved actual or threatened death or serious injury, or a threat to the physical integrity of self or others.4 For the DSM classification, the person must also have experienced intense fear, helplessness, or horror when the event occurred. The symptoms must have been present for at least one month (the one month criterion does not apply in the ICD-10 classification) and, crucially, they must also cause clinically significant distress or impairment in social, occupational, or other important areas of …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012